Enzyme Immunoassay-Based Platform for Accurate Detection of Serum Pathological α-Synuclein in Parkinson's Disease Patients.

ACS Chemical Neuroscience
Benjamin W SchlichtmannBalaji Narasimhan

Abstract

An assay for accurately diagnosing early stage Parkinson's Disease (PD) is currently unavailable, and therefore, there is an urgent and unmet need. Such a diagnostic assay will enable prompt institution of appropriate supportive management measures to prevent rapid deterioration of disease and improve both quality of life and life expectancy of PD patients. A reliable assay platform will also be of great benefit to drug discovery and drug development in the area of PD. To this end, we describe the development of two indirect, competitive, semiquantitative enzyme immunoassays (EIAs), each employing a disparate singularly specific mouse monoclonal antibody (ssMAb) against pathological aggregates of human α-Synuclein (αSynagg), a well-established biomarker pathognomonic of PD. Our results demonstrate that these EIAs in tandem accurately discriminated between αSynagg serum concentrations from PD patients and age-matched healthy control (HC) individuals (PD = 1700 ± 220 ng/mL; HC = 870 ± 120 ng/mL with an overall sensitivity of 56%, specificity of 63%, positive predictive value of 60%, and negative predictive value of 59%). The limits of detection of αSynagg were 400 and 300 pg/mL for ssMAbs 3C5 and 5H6, respectively. These tandem E...Continue Reading

References

Mar 2, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Omar M A El-AgnafDavid Allsop
Apr 29, 2009·International Journal of Molecular Sciences·Katrin BeyerAurelio Ariza
Jul 22, 2010·Journal of Neuroscience Research·R B TinsleyM K Horne
Aug 26, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Penelope G FouldsDavid Allsop
Nov 9, 2011·The International Journal of Neuroscience·Charles H Adler
Nov 15, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Kurt A Jellinger
Aug 30, 2013·Scientific Reports·Penelope G FouldsDavid Allsop
Apr 7, 2015·PloS One·Niklas K U KoehlerElke Richartz-Salzburger
Apr 22, 2015·Seizure : the Journal of the British Epilepsy Association·Hu RongZhiqin Xi
Jan 1, 2016·Revue neurologique·A ElbazF Moisan
Mar 5, 2016·Brain Pathology·Anzari AtikJing Zhang
Oct 19, 2016·Annals of Clinical and Translational Neurology·Graham FairfoulAlison J E Green
Jan 14, 2017·Brain : a Journal of Neurology·Sirwan K L DarweeshM Arfan Ikram
Feb 17, 2017·Parkinsonism & Related Disorders·Arun Parashar, Malairaman Udayabanu
May 28, 2017·European Journal of Pharmacology·Paula Perez-PardoAletta D Kraneveld
May 28, 2017·Journal of Neurology, Neurosurgery, and Psychiatry·Chin-Hsien LinMing-Jang Chiu
Jul 28, 2017·Nature Reviews. Neuroscience·James B KoprichJonathan M Brotchie
Oct 27, 2018·Frontiers in Aging Neuroscience·Runcheng HeQiying Sun
Nov 16, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Inger van SteenovenOmar M A El-Agnaf
Jan 27, 2019·ACS Chemical Neuroscience·Houqian GaoLing Zhu
Jan 29, 2019·Ageing Research Reviews·Jessica Y VargasChiara Zurzolo
Feb 2, 2019·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Sireesha ManneAnumantha G Kanthasamy
Feb 24, 2019·Parkinsonism & Related Disorders·Giorgio VivacquaAlfredo Berardelli
Feb 26, 2019·Annals of Neurology·Niccolò CandeliseInga Zerr
Jul 3, 2019·Biomarkers in Medicine·Sarah F Hamm-AlvarezMark F Lew
Nov 24, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Sireesha ManneAnumantha G Kanthasamy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.